Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Xinhua Education Group Limited (2779.HK)
Hefei, CN
China Xinhua Education Group Limited, together with its subsidiaries, provides higher and secondary vocational education services in the People's Republic of China. The company operates four private schools, which include Anhui Xinhua University that offers undergraduate and junior college programs focusing on engineering and management, economics, education, literature, medical studies, and arts; Clinical College of Anhui Medical University, an undergraduate university that offers a range of medical undergraduate courses, including clinical medicine, pharmacy, public affairs management, nursing, biomedical engineering, rehabilitation therapy, and medical imaging technique; Nanjing University of Finance & Economics Hongshan College; and Anhui Xinhua School, a full-time secondary vocational school. It also offers technical and management consultancy services. China Xinhua Education Group Limited was founded in 1999 and is headquartered in Hefei, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.44% | -5.88% | -15.79% | -29.82% | -31.03% | -28.57% | -32.20% | -48.05% | -82.53% | -87.73% | -87.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%+1.5% Q4'25: +1.3% (vs Q4'23)
-
EPS growth Personal Products & Services: +19.6%+0.0% Q4'25: -35.0% (vs Q4'23)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+47.2% Q4'25: +148.2% (vs Q4'23)
-
EBIT margin Personal Products & Services: +10.5%+51.0% ★ Q4'25: +26.6% (vs Q4'23)
-
ROIC Personal Products & Services: +6.9%+8.4% ★ Q4'25: +7.8% (vs Q4'23)
-
Share dilution Personal Products & Services: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×1.40× ★ Q4'25: 1.40× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
386.13M
est: 444.25M (-13.1%)
|
437.73M
est: 559.30M (-21.7%)
|
478.85M
est: 581.04M (-17.6%)
|
565.39M
est: 817.42M (-30.8%)
|
625.48M
est: 787.87M (-20.6%)
|
642.66M
est: 766.95M (-16.2%)
|
648.08M
est: 776.05M (-16.5%)
|
658.03M
est: 803.68M (-18.1%)
|
| EBITDA |
313.78M
est: 298.60M (+5.1%)
|
334.63M
est: 333.29M (+0.4%)
|
401.70M
est: 290.52M (+38.3%)
|
440.83M
est: 334.27M (+31.9%)
|
324.40M
est: 417.55M (-22.3%)
|
393.12M
est: 521.68M (-24.6%)
|
396.49M
est: 482.18M (-17.8%)
|
384.81M
est: 499.35M (-22.9%)
|
| EBIT |
258.08M
est: 249.72M (+3.3%)
|
274.60M
est: 276.53M (-0.7%)
|
340.53M
est: 239.61M (+42.1%)
|
374.75M
est: 275.70M (+35.9%)
|
255.20M
est: 344.39M (-25.9%)
|
327.46M
est: 430.27M (-23.9%)
|
336.42M
est: 404.98M (-16.9%)
|
335.44M
est: 419.40M (-20.0%)
|
| Net Income |
256.01M
est: 291.91M (-12.3%)
|
270.67M
est: 274.31M (-1.3%)
|
325.29M
est: 236.18M (+37.7%)
|
354.48M
est: 271.76M (+30.4%)
|
235.51M
est: 244.47M (-3.7%)
|
307.10M
est: 351.00M (-12.5%)
|
330.22M
est: 413.82M (-20.2%)
|
338.05M
est: 428.74M (-21.2%)
|
| SGA |
64.08M
est: 74.36M (-13.8%)
|
102.06M
est: 68.66M (+48.6%)
|
77.58M
est: 89.05M (-12.9%)
|
78.42M
est: 102.46M (-23.5%)
|
166.27M
est: 127.99M (+29.9%)
|
84.12M
est: 159.91M (-47.4%)
|
90.42M
est: 114.85M (-21.3%)
|
42.77M
est: 118.93M (-64.0%)
|
| EPS |
0.17
est: 0.18 (-6.3%)
|
0.17
est: 0.21 (-17.8%)
|
0.20
est: 0.22 (-8.9%)
|
0.22
est: 0.30 (-25.9%)
|
0.15
est: 0.31 (-51.3%)
|
0.19
est: 0.25 (-24.3%)
|
0.21
est: 0.26 (-18.4%)
|
0.21
est: 0.27 (-21.2%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-28 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-27 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-26 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-22 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-20 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 1/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yongkai Wang | Executive Director & Executive President | 766.7K | male |
| Zhen Lu | Executive Vice President | 609.6K | male |
| Ming Chen | Executive Director | 418.0K | female |
| Junbao Wu | Founder & Chairman | 416.8K | male |
| Ming Zhang | Executive Director & President | 196.3K | male |
| Anne Yu | Company Secretary | — | female |
| Zheng Ni | Chief Officer of International Operations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2779.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
